Income Taxes
The Company adopted ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Taxes Disclosures (“ASU 2023-09”) on a retrospective basis. See Note 2 for additional information.
Income before income tax expense was attributable to the following jurisdictions:
(In thousands)December 31, 2025December 31, 2024December 31, 2023
U.S. $442,512 $378,092 $295,567 
Foreign8,744 5,331 7,021 
Income before income taxes$451,256 $383,423 $302,588 
The components of income tax expense as shown in our Consolidated Statements of Operations were as follows:
(In thousands)December 31, 2025December 31, 2024December 31, 2023
Current tax expense/(benefit)
Federal$39,407 $54,547 $56,139 
Foreign2,681 2,360 2,590 
State and local26,659 24,751 30,901 
Total current tax expense68,747 81,658 89,630 
Deferred tax expense/(benefit)
Federal34,589 4,713 (12,715)
Foreign(280)— — 
State and local4,219 3,227 (7,079)
Total deferred tax expense/(benefit)38,528 7,940 (19,794)
Income tax expense$107,275 $89,598 $69,836 
The following table is a reconciliation of the U.S. federal statutory rate of 21% to the Company’s effective rate for the years ended December 31, 2025, December 31, 2024, and December 31, 2023, respectively, in accordance with the guidance in ASU 2023-09.
December 31, 2025
December 31, 2024(1)
December 31, 2023(1)
(In thousands)Amount% of
Pre-tax
Amount% of
Pre-tax
Amount% of
Pre-tax
U.S. Federal statutory tax rate$94,764 21.0 $80,519 21.0 $63,544 21.0 
State and local income taxes, net of Federal Income tax effect(2)
24,413 5.4 21,043 5.5 18,445 6.1 
Foreign tax effects
Other foreign jurisdictions2,201 0.5 2,572 0.7 2,448 0.8 
Effect of cross-border tax laws
Foreign-derived intangible income(2,957)(0.7)(4,706)(1.2)(3,985)(1.3)
Tax credits
Research and development tax credits(13,181)(2.9)(9,518)(2.5)(12,683)(4.2)
Other(2,894)(0.6)(3,825)(1.0)(2,209)(0.7)
Changes in valuation allowances439 0.1 2,092 0.5 — — 
Nontaxable or nondeductible Items
Nondeductible executive compensation6,488 1.4 2,154 0.6 2,175 0.7 
Stock-based awards (benefit)/expense(3,829)(0.8)154 — 478 0.2 
Other1,436 0.3 881 0.2 (111)— 
Changes in unrecognized tax benefits61  (1,728)(0.5)1,763 0.6 
Other adjustments334 0.1 (40)— (29)— 
Income tax expense$107,275 23.8 $89,598 23.3 $69,836 23.2 
(1)Prior periods presented have been recast to conform to the current presentation. See Note 2 for additional information.
(2)The majority (greater than 50 percent) of the tax effect in the state and local taxes was attributable to California, New York and New York City for the year ended December 31, 2025; California, Illinois, New Jersey, New York and New York City for the year ended December 31, 2024; and California, Massachusetts, New Jersey, New York and New York City for the year ended December 31, 2023.
The components of the net deferred tax assets and liabilities recognized in our Consolidated Balance Sheets were as follows:
(In thousands)December 31, 2025December 31, 2024
Deferred tax assets
Retirement, postemployment and deferred compensation plans$52,828 $54,464 
Accruals for other employee benefits, compensation, insurance and other19,973 17,482 
Net operating losses26,999 35,837 
Operating lease liabilities12,911 12,643 
Capitalized research and experimentation costs50,705 94,930 
Other23,592 27,919 
Gross deferred tax assets$187,008 $243,275 
Valuation allowance(6,881)(5,332)
Net deferred tax assets$180,127 $237,943 
Deferred tax liabilities
Property, plant and equipment$21,510 $31,401 
Intangible assets68,062 73,536 
Operating lease right-of-use assets9,120 8,774 
Other8,638 12,835 
Gross deferred tax liabilities$107,330 $126,546 
Net deferred tax asset$72,797 $111,397 
On July 4, 2025, the One Big Beautiful Bill Act (the “OBBBA”) was enacted into law. The OBBBA includes provisions retroactive to January 1, 2025, and, among other provisions, eliminates the requirement to capitalize and amortize domestic research and experimentation expenditures over five years and provides an election for taxpayers to deduct such expenditures in the year incurred. These changes resulted in lower cash tax payments during the fiscal year ended December 31, 2025.
Federal tax operating loss carryforwards acquired in connection with The Athletic Media Company acquisition totaled $20 million as of December 31, 2025. Such losses have remaining lives of up to 12 years. State tax operating loss carryforwards totaled $7.4 million as of December 31, 2025, and $6.9 million as of December 31, 2024. Such loss carryforwards expire in accordance with provisions of applicable tax laws and have remaining lives of up to 17 years. Foreign tax operating loss carryforwards totaled $1.1 million as of December 31, 2025, most of which have an indefinite carryforward period.
We assess whether a valuation allowance should be established against deferred tax assets based on the consideration of both positive and negative evidence using a “more likely than not” standard. In making such judgments, significant weight is given to evidence that can be objectively verified. We evaluated our deferred tax assets for recoverability using a consistent approach that considers our three-year historical cumulative income/(loss), including an assessment of the degree to which any such losses were due to items that are unusual in nature (i.e., impairments of nondeductible goodwill and intangible assets).
We had a valuation allowance totaling $6.9 million as of December 31, 2025, and $5.3 million as of December 31, 2024, for deferred tax assets primarily associated with net operating losses of U.S. and foreign subsidiaries and U.S. foreign tax credits, as we determined that these assets were not realizable on a more-likely-than-not basis.
As of December 31, 2025, and December 31, 2024, Accumulated other comprehensive loss, net of income taxes in our Consolidated Balance Sheets and for the years then ended in our Consolidated Statements of Changes in Stockholders’ Equity was net of deferred tax assets of approximately $141 million and $140 million, respectively.
We had a prepaid income tax asset of $5.1 million as of December 31, 2025, compared with a prepaid income tax asset of $5.6 million as of December 31, 2024.
Total income taxes paid (net of refunds received), disaggregated by federal (national), state and local, and foreign taxes, were as follows:
(In thousands)December 31, 2025December 31, 2024December 31, 2023
Federal$39,997 $79,000 $45,001 
State and local29,250 31,183 24,582 
Foreign2,699 2,908 2,231 
Total income taxes paid (net of refunds)$71,946 $113,091 $71,814 
Income taxes paid (net of refunds) exceeded five percent of total income taxes paid (net of refunds) in the following jurisdictions:
(In thousands)December 31, 2025December 31, 2024December 31, 2023
State and local
California$4,924 **
New York5,300 *6,500 
New York City6,762 *5,100 
*Jurisdiction below the threshold for the period presented.
A reconciliation of unrecognized tax benefits is as follows:
(In thousands)December 31, 2025December 31, 2024December 31, 2023
Balance at beginning of year$4,932 $7,074 $5,528 
Gross additions to tax positions taken during the current year1,738 840 2,466 
Gross additions to tax positions taken during the prior year 1,630 877 
Gross reductions for tax positions taken during the prior year(840)(2,305)(8)
Reductions from settlements with taxing authorities(1,764)(1,924)(1,185)
Reductions from lapse of applicable statutes of limitations(254)(383)(604)
Balance at end of year$3,812 $4,932 $7,074 
The total amount of unrecognized tax benefits that would, if recognized, affect the effective income tax rate was approximately $3 million and $4 million as of December 31, 2025, and December 31, 2024, respectively.
In 2025 and 2024, we recorded a $1.1 million and a $5.7 million income tax benefit, respectively, due to a reduction in the Company’s reserve for uncertain tax positions.
We also recognize accrued interest expense and penalties related to the unrecognized tax benefits within income tax expense or benefit. The total amount of accrued interest and penalties was $0.4 million and $2.5 million as of December 31, 2025, and December 31, 2024, respectively. The total amount of accrued interest and penalties was a net benefit of $2.1 million in 2025, a net expense of $0.5 million in 2024 and a net expense of $0.3 million in 2023.
With few exceptions, we are no longer subject to U.S. federal, state and local or non-U.S. income tax examinations by tax authorities for years prior to 2015. Management believes that our accrual for tax liabilities is adequate for all open audit years. This assessment relies on estimates and assumptions and may involve a series of complex judgments about future events.

Historical Timeline

Fiscal YearFiled
2025Feb 27, 2026Showing above
2024Feb 27, 2025
2023Feb 20, 2024
2022Feb 28, 2023
2021Feb 23, 2022
2020Feb 25, 2021
2019Feb 27, 2020
2018Feb 26, 2019
2017Feb 27, 2018
2016Feb 22, 2017
2015Feb 24, 2016

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.